PharmaCyte Biotech, Inc. PMCB
Set alert
0.34 USD +0.02 +6.35%
As of Nov 3, 12:48 PM ET
0.3164 Day range 0.335
0.3021 52-week range 1.51
- YTD
- -53.73%
- 1 year
- -63.48%
- Open
- 0.3164
- Prev close
- 0.315
- Mkt cap
- 3.60M
- Vol
- 6.90K
- Avg vol
- 183.73K
- EPS
- -2.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.3164
- High
- 0.335
- Forward P/E
- -4.21
- Beta
- -0.20
- Short ratio
- 1.09
- Inst. own
- 13.16%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.73
- 200-d avg
- 1.94
- 1y target
- 0.00
MAX chart
Signals (38)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 1, 2023 | 3 years ago |
| SMA: Bullish | Jul 1, 2022 | 4 years ago |
| MACD: Buy Signal | Jan 1, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 1, 2021 | 5 years ago |
| SMA: Bearish | May 1, 2021 | 5 years ago |
| MACD: Buy Signal | Feb 1, 2021 | 5 years ago |
| SMA: Bullish | Jan 1, 2021 | 5 years ago |
| MACD: Sell Signal | May 1, 2020 | 6 years ago |
| SMA: Bearish | Mar 1, 2020 | 6 years ago |
| SMA: Bearish | Mar 1, 2020 | 6 years ago |
| SMA: Bullish | Jan 1, 2020 | 6 years ago |
| SMA: Bullish | Dec 1, 2019 | 6 years ago |
| SMA: Bearish | Mar 1, 2019 | 7 years ago |
| SMA: Bullish | Feb 1, 2019 | 7 years ago |
| MACD: Buy Signal | Feb 1, 2019 | 7 years ago |
| MACD: Sell Signal | Jan 1, 2019 | 7 years ago |
Newest 20 of 38.
Financial health
Altman Z-Score
-3.39 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.3×
FY 2017 5y median -1.2× FY 2026
P/S 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 0.2×
FY 2017 5y median 0.2× FY 2026
P/FCF -1.0×
FY 2017 5y median -3.1× FY 2026
EV/EBITDA 2.6×
FY 2017 5y median 2.6× FY 2026
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -101.8%
FY 2017 5y median -32.8% FY 2026
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -58.3%
FY 2017 5y median -4.7% FY 2026
ROIC -14.9%
FY 2017 5y median -8.9% FY 2026
ROA -41.5%
FY 2017 5y median -4.7% FY 2026
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2026
Operating Income -56.6%
FY 2017 FY 2026
EPS (diluted) -186.8%
FY 2017 FY 2026
Free Cash Flow -73.0%
FY 2017 FY 2026
Financial Health
Current Ratio 45.3×
FY 2017 5y median 45.3× FY 2026
Quick Ratio 45.3×
FY 2017 5y median 45.3× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 3.5×
FY 2017 5y median 7.7× FY 2026
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2026
Dividends
Dividend Yield 4.9%
FY 2017 5y median 0.0% FY 2026
Payout Ratio -1.3%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-04-30
